ArticleRSC advances2024
Nanomolar detection of lurasidone hydrochloride in pharmaceutical formulations (Serodopamoun®) and spiked urine using a PVC/imprinted polymer/MWCNTs layer deposited onto polyaniline-coated screen-printed electrodes.
Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Pico-molar determination of lurasidone hydrochloride in pharmaceutical formulations using PVC-membrane bulk Miptode.RSC advances · 2026Article
- Redox chemistry, catalysis, and electrochemical detection of periodate species: sensors, mechanisms, and applications in green chemistry.Frontiers in chemistry · 2026Review
- Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study developed potentiometric sensors for detecting lurasidone HCl (LSH), a vital drug for treating schizophrenia and bipolar I disorder, in pharmaceutical formulations and biological samples. The sensors are based on screen-printed electrodes (SPE) modified with a molecularly imprinted polymer (MIP) synthesized using lurasidone as a template, 1-vinyl-2-pyrrolidine (VP) as a functional monomer, ethylene glycol dimethacrylate (EGDMA) as a crosslinker, and benzoyl peroxide as an initiator. The SPE was further modified with a conductive polyaniline (PANI) film and a polyvinyl chloride (PVC) layer containing MIP as an ionophore and multiwalled carbon nanotubes (MWCNT) as a transducing material along with 2-nitrophenyl octyl ether (2-NPOE) as plasticizer. This configuration resulted in a sensor with a sensitive response and high selectivity for LSH. The electrochemical evaluation showed a Nernstian response slope of 57.3 ± 0.5 mV decade
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.